iSERA Lifesciences LimitedBSE: COVIDH

Isera Lifesciences Limited Press Release Jul 28 2025

· Issued by iSERA Lifesciences Limited via BSE India

Filed with BSE ·

The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on July 25, 2025 for Ganapa Narsi Reddy

View Attachment

6ix hasn’t read this filing yet.

iSERA Lifesciences Limited on 6ix

Earlier from iSERA Lifesciences

Later from iSERA Lifesciences

All iSERA Lifesciences news releases